GPT Healthcare balance sheet

As of Mar 2026

Total assets: ₹465cr+20.9% on Mar 2025
Shareholders' equity: ₹269cr+8.7% on Mar 2025
Total debt: ₹16.1cr+21.1% on Mar 2025
Cash and investments: ₹47.1cr+39.9% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024

Non-current assets
	265	203	201
	0.7	46.3	6.4
	0.5	1.0	0.8
	76.3	24.3	22.1
	0.0	0.0	19.2
	0.1	0.2	0.1
	19.3	16.4	9.7
	19.4	16.6	29.0
	13.1	14.6	6.0
	375	305	265
Current assets
	10.6	8.8	8.2
	42.9	32.0	11.2
	20.3	24.9	24.3
	4.1	1.7	1.7
	0.3	2.6	7.4
	1.2	0.2	11.2
	0.8	6.4	14.6
	69.7	67.7	70.4
	9.0	2.3	1.6
	89.3	78.8	80.2
	465	384	346
Equity
	82.1	82.1	82.1
	187	166	136
	269	248	218
	269	248	218
Liabilities
	7.2	5.5	3.6
	69.5	17.2	15.3
	76.7	22.7	19.0
	8.7	9.5	7.5
	19.6	19.3	12.0
	10.8	10.7	11.3
	116	62.2	49.8
	8.9	7.8	8.8
	41.9	34.8	37.4
	22.1	25.0	17.6
	73.0	67.5	63.8
	0.2	0.6	6.4
	6.3	6.1	7.0
	79.5	74.2	77.2
	195	136	127
	465	384	346
Trade payables — MSME split
	1.1	0.8	—
	40.9	33.9	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

GPTHEALTH₹132.20

GPT Healthcare Limited

· Pharma & Health

₹ CrorePeersGKSL SHALBY INDRAMEDCO LOTUSEYE ARTEMISMED DRAGARWQ KMCSHIL KOVAIMcap ₹1,085 Cr

View

In ₹ Crore except Per Share As of	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	201.1	202.6	265.4	265.4
+ Capital Work-in-Progress	6.4	46.3	0.7	0.7
+ Other Intangibles	0.8	1.0	0.5	0.5
+ Intangibles under Development	22.1	24.3	76.3	76.3
+ Non-current Investments	19.2	0.0	0.0	0.0
+ Long-term Loans	0.1	0.2	0.1	0.1
+ Other Non-current Financial Assets	9.7	16.4	19.3	19.3
Non-current Financial Assets	29.0	16.6	19.4	19.4
+ Other Non-current Assets	6.0	14.6	13.1	13.1
Total Non-current Assets	265.4	305.4	375.5	375.5
Current Assets
+ Inventories	8.2	8.8	10.6	10.6
+ Current Investments	11.2	32.0	42.9	42.9
+ Trade Receivables	24.3	24.9	20.3	20.3
+ Cash & Cash Equivalents	1.7	1.7	4.1	4.1
+ Other Bank Balances	7.4	2.6	0.3	0.3
+ Short-term Loans	11.2	0.2	1.2	1.2
+ Other Current Financial Assets	14.6	6.4	0.8	0.8
Current Financial Assets	70.4	67.7	69.7	69.7
+ Other Current Assets	1.6	2.3	9.0	9.0
Total Current Assets	80.2	78.8	89.3	89.3
Total Assets	345.5	384.3	464.7	464.7
Equity
+ Equity Share Capital	82.1	82.1	82.1	82.1
+ Other Equity / Reserves	136.4	165.8	187.4	187.4
Equity — Owners of Parent	218.5	247.9	269.4	269.4
Total Equity	218.5	247.9	269.4	269.4
Liabilities
+ Borrowings — Non-current	3.6	5.5	7.2	7.2
+ Other Non-current Financial Liab	15.3	17.2	69.5	69.5
Non-current Financial Liabilities	19.0	22.7	76.7	76.7
+ Provisions — Non-current	7.5	9.5	8.7	8.7
+ Deferred Tax Liabilities	12.0	19.3	19.6	19.6
+ Other Non-current Liabilities	11.3	10.7	10.8	10.8
Non-current Liabilities	49.8	62.2	115.8	115.8
+ Borrowings — Current	8.8	7.8	8.9	8.9
+ Trade Payables	37.4	34.8	41.9	41.9
+ Other Current Financial Liab	17.6	25.0	22.1	22.1
Current Financial Liabilities	63.8	67.5	73.0	73.0
+ Provisions — Current	6.4	0.6	0.2	0.2
+ Other Current Liabilities	7.0	6.1	6.3	6.3
Current Liabilities	77.2	74.2	79.5	79.5
Total Liabilities	127.0	136.4	195.3	195.3
Total Equity & Liabilities	345.5	384.3	464.7	464.7
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	0.8	1.1	1.1
+ Dues to Other Creditors — Current	—	33.9	40.9	40.9

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.